Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia (AsiaLymph)

NCT01584141 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01584141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01584141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia (AsiaLymph)
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
July 5, 2011
Completion date
July 10, 2018
Enrollment
13,433 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, leukemia, lymphoma, follicular, lymphoma, non-hodgkin, lympocytic, follicular, multiple myleoma